Using Western blotting and quantitative PCR, we found that the expression levels of FAP, α-SMA, and S100A4 were significantly higher in CAFs compared to NAFs (Fig. 3b), confirming the successful extraction of primary CAFs from gastric cancer patients. The gene discussed is S100A4; the disease is gastric cancer.